ArticleEncephalitis (Seoul, Korea)2026
A narrative review of antiseizure medication adherence in epilepsy: determinants to clinical implications.
Article in Encephalitis (Seoul, Korea), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Medication Adherence and Quality of Life in Epilepsy: The Potential Role of Seizure Severity in the Association Between Them.Journal of clinical medicine · 2026Article
- Intranasal Biodegradable Nanomedicine for Epilepsy Management: Targeting the Brain Beyond the Blood-Brain Barrier.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Achieving optimal seizure control without recurrence is a critical goal in epilepsy. When evaluating whether treatment is effective, medication adherence must be carefully considered but has traditionally been overlooked. In this study, we introduce commonly used definitions of medication adherence and examine adherence findings in epilepsy and other chronic diseases. Factors influencing adherence are analyzed according to three domains: the characteristics of the medication itself, patient-related factors, and environmental or socioeconomic influences. Considering not only the pharmacologic properties of antiseizure medications but also the roles of social and economic support in clinical practice may help reduce the risk of breakthrough seizures and early mortality in patients with epilepsy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.